Viral Haemorrhagic Fever, Dengue Fever
Conditions
Brief summary
To meet eligibility criteria, this study and informed consent of the syndrome of fever associated with bleeding of infectious diseases, severe patients to carry out multicenter, practical randomized controlled clinical research, to compare the curative effect of western medicine, combining Chinese and western medicine treatment, and security, and pathogenesis of TCM and syndrome, severe immune related factor and syndrome type of traditional Chinese medicine, Chinese medicine prescriptions mechanism research.
Detailed description
Randomized method: using large sample, central randomized, parallel comparison of Chinese and western medicine and western medicine group.
Interventions
DRUGWestern Medicine
Physical cooling,Hydrocortisone
DRUGTCM and Western Medicine
Third Infectious diseases soup recipe
Sponsors
Guangzhou 8th People's Hospital
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Viral diseases, such as dengue fever, kidney of hemorrhagic fever, such as xinjiang hemorrhagic fever; Or clinical has fever associated with bleeding as the main performance, and confirmed as the new emergent infectious diseases
Exclusion criteria
* Diagnosed with flu, hand, foot and mouth disease, viral hepatitis (except the carrier), liver cirrhosis after hepatitis, AIDS, rabies, encephalitis, polio, measles, German measles, chickenpox, herpes, infectious mononucleosis, infectious atypical pneumonia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality | Anytime of the clinical trail from 2011.1.1 to 2015.12.30 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Safety outcome | From 2012.1 to 2015.12 | With adverse events as the calculation basis |
Countries
China
Contacts
Primary ContactTan X Hua
Outcome results
None listed